In 2025, respiratory news highlighted advances in lung imaging, expanded support for pulmonary rehabilitation and promising ...
SurvivorNet on MSN
Enhertu significantly cuts recurrence rates for women with high-risk HER2-positive breast cancer — the practice-changing DESTINY-Breast05 trial
DESTINY-Breast05 is a large phase 3 trial in women with HER2-positive early-stage breast cancer who had chemotherapy and ...
Projects include advancing control strategies against common hog industry diseases, helping humans by increasing the use of ...
A proof-of-concept trial shows novel sarcoidosis PET/CT tracer detects inflammatory activity, supporting further clinical ...
Full MIST2 dosing of intrapleural enzyme therapy varies widely across hospitals and is associated with a lower risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback